Testing effectiveness (Phase 2)Not Yet RecruitingNCT05931757
What this trial is testing
Olverembatinib Combined With Blinatumomab in the Treatment of Ph+ ALL
Who this might be right for
Philadelphia-Positive ALL
The First Affiliated Hospital of Soochow University 22